B591 a novel specific panPI3K inhibitor preferentially targets cancer stem cells

B591, a novel specific pan-PI3K inhibitor, preferentially targets cancer stem cells

05:36 EST 12 Jan 2019 | Nature Publishing

More From BioPortfolio on "B591, a novel specific pan-PI3K inhibitor, preferentially targets cancer stem cells"